Related references
Note: Only part of the references are listed.Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease
Svetlana Hakobyan et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Convergent genetic and expression data implicate immunity in Alzheimer's disease
Lesley Jones et al.
ALZHEIMERS & DEMENTIA (2015)
Common polygenic variation enhances risk prediction for Alzheimer's disease
Valentina Escott-Price et al.
BRAIN (2015)
The role of complement in neurological and neuropsychiatric diseases
Bryan Paul Morgan
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
A study on the association between infectious burden and Alzheimer's disease
X. -L. Bu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease
Wesley Jongbloed et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Coding variants in TREM2 increase risk for Alzheimer's disease
Sheng Chih Jin et al.
HUMAN MOLECULAR GENETICS (2014)
Traumatic brain injury and risk of dementia in older veterans
Deborah E. Barnes et al.
NEUROLOGY (2014)
The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer's Disease
Federico Licastro et al.
IMMUNITY & AGEING (2014)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
Madhav Thambisetty et al.
NEUROIMAGE (2012)
Plasma Clusterin and the Risk of Alzheimer Disease
Elisabeth M. C. Schrijvers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
Madhav Thambisetty et al.
PLOS ONE (2011)
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Madhav Thambisetty et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease
Minerva M. Carrasquillo et al.
ARCHIVES OF NEUROLOGY (2010)
Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
Gyungah Jun et al.
ARCHIVES OF NEUROLOGY (2010)
Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals
Jason J. Corneveaux et al.
HUMAN MOLECULAR GENETICS (2010)
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Sudha Seshadri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis
Jean-Charles Lambert et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Plaque complement activation and cognitive loss in Alzheimer's disease
David A. Loeffler et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Protective effects of NSAIDs on the development of Alzheimer disease
Steven C. Vlad et al.
NEUROLOGY (2008)
Proteome-based plasma biomarkers for Alzheimer's disease
A. Hye et al.
BRAIN (2006)
Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication
S Fleminger et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Share Paper
